Example: Heart Attack

Search clinical trials for: Medroxyprogesterone Acetate

Total 181 results

NCT02340013

Completed

Endometrial Shedding Prior to Ovulation Induction Pilot Study

Conditions: Infertility
NCT03395756

Completed

Depot Medroxyprogesterone Acetate as Emergency Contraception

Conditions: Emergency Contraception; Contraception
NCT01143207

Completed

PK of Depo SubQ Injected in the Upper Arm

Conditions: Contraception
NCT00830414

Completed

Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women

Conditions: Healthy
NCT01296152

Completed

Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women

Conditions: HIV-1 Infection
NCT01463202

Completed

Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression

Conditions: Contraception; Postpartum Depression; Lactation
NCT01461824

Completed

Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects

Conditions: Weight Gain; Disorder of Bone Density and Structure, Unspecified; Uterine Bleeding
NCT02412436

Completed

PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB

Conditions: HIV-1 Infection; Tuberculosis
NCT02509767

Completed

Depo Provera Self-Administration Study: Putting a Patient-Centered Practice to the Test at Planned Parenthood

Conditions: Contraception
NCT00563576

Completed

Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation

Conditions: Metrorrhagia
NCT02732418

Completed

Lower Dose Depo Provera® Contraceptive Injection

Conditions: Contraception
NCT04710017

Recruiting

Tranexamic Acid and Depot-Medroxyprogesterone Acetate for Perimenopausal Irregular Uterine Bleeding

Conditions: Irregular Uterine Bleeding
NCT02335203

Unknown status

The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy

Conditions: Grade 1 Endometrial Endometrioid Adenocarcinoma; Grade 2 Endometrial Endometrioid Adenocarcinoma; Complex Atypical Endometrial Hyperplasia
NCT03675139

Recruiting

MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia

Conditions: Endometrial Hyperplasia Without Atypia
NCT01191203

Completed

Randomized Control Trial Copper Intrauterine Device and Depo-medroxyprogesterone Acetate (DMPA) of HIV+ Women in Malawi

Conditions: HIV
NCT01019369

Completed

Study of Self or Clinic Administration of DepoProvera

Conditions: Contraception
NCT01776203

Terminated

Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist

Conditions: Dysfunctional Uterine Bleeding
NCT00064025

Completed

Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus

Conditions: Endometrial Adenocarcinoma; Endometrial Adenosquamous Carcinoma; Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation; Recurrent Uterine Corpus Carcinoma; Stage I Uterine Corpus Cancer; Stage II Uterine Corpus Cancer; Stage III Uterine Corpus Cancer; Stage IV Uterine Corpus Cancer
NCT03300960

Completed

Usefulness of Medroxyprogesterone Acetate in Follicular Phase in Oocyte Donors. Undergoing Ovarian Stimulation

Conditions: Infertility
NCT02103764

Unknown status

Efficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUB

Conditions: Dysfunctional Uterine Bleeding
NCT03309176

Completed

"Stair Step Study"

Conditions: Ovulation Disorder
NCT03018249

Active, not recruiting

Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer

Conditions: FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma; FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma; FIGO Grade 3 Endometrial Endometrioid Adenocarcinoma
NCT01791413

Completed

Effect of Pre-operative Depo Medroxyprogesterone Acetate on Serum Anti-mullerian Hormone Level After Laparoscopic Ovarian Cystectomy of Endometriomas

Conditions: Endometriosis
NCT02449161

Recruiting

The Effect of Post Ablation Medroxyprogesterone Acetate on Endometrial Amenorrhea Rates

Conditions: Menorrhagia
NCT00360490

Completed

Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)

Conditions: Menorrhagia